Citation: Hp. Li et al., NEW TECHNIQUE TO CONTROL IN-SITU OXYGEN FUGACITY IN WATER-FREE HIGH-PRESSURE SYSTEM - USING CU-O AS AN EXAMPLE, Chinese Science Bulletin, 43(16), 1998, pp. 1353-1358
Authors:
HUANG SL
XIE HG
WANG W
XU ZH
JIANG CH
ZHOU HH
Citation: Sl. Huang et al., DETERMINATION OF S R RATIO OF MEPHENYTOIN IN HUMAN URINE BY CHIRAL HPLC AND ULTRAVIOLET DETECTION AND ITS COMPARISON WITH GAS-CHROMATOGRAPHY/, Zhongguo yaoli xuebao, 19(6), 1998, pp. 548-550
Citation: Ds. Ouyang et al., USE OF CAFFEINE AS A PROBE FOR RAPID-DETERMINATION OF CYTOCHROME-P-450 CYP1A2 ACTIVITY IN HUMANS, Zhongguo yaoli xuebao, 19(1), 1998, pp. 44-46
Citation: Hg. Xie, HOW TO CORRECTLY CALCULATE THE PROPORTIONS OF THE HETEROZYGOTES AND HOMOZYGOTES IN THE EXTENSIVE METABOLIZERS OF A CERTAIN DRUG-METABOLIZING ENZYME IN AN ETHNIC OR RACIAL POPULATION, Clinical pharmacology and therapeutics, 64(5), 1998, pp. 575-575
Citation: Hg. Xie et al., DISTRIBUTION OF GENETIC POLYMORPHISMS OF BETA-2-ADRENOCEPTOR GENE BETWEEN BLACK-AND-WHITE POPULATIONS, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 78-78
Authors:
XIE HG
HUANG SL
XU ZH
XIAO XS
HE N
ZHOU HH
Citation: Hg. Xie et al., EVIDENCE FOR THE EFFECT OF GENDER ON ACTIVITY OF (S)-MEPHENYTOIN 4'-HYDROXYLASE (CYP2C19) IN A CHINESE POPULATION, Pharmacogenetics, 7(2), 1997, pp. 115-119
Authors:
XIE HG
HUANG SL
XU ZH
XIAO XS
HE N
ZHOU HH
Citation: Hg. Xie et al., EVIDENCE FOR THE EFFECT OF GENDER ON ACTIVITY OF (S)-MEPHENYTOIN 4'-HYDROXYLASE (CYP2C19) IN A CHINESE POPULATION, Pharmacogenetics, 7(2), 1997, pp. 115-119
Citation: Js. Wang et al., EFFECT OF TROLEANDOMYCIN ON THE PHARMACOKINETICS OF IMIPRAMINE IN CHINESE - THE ROLE OF CYP3A, British journal of clinical pharmacology, 44(2), 1997, pp. 195-198
Citation: Hg. Xie et al., NO CORRELATION BETWEEN SIDE-CHAIN OF PROPRANOLOL OXIDATION AND S-MEPHENYTOIN 4'-HYDROXYLASE ACTIVITY, Zhongguo yaoli xuebao, 18(3), 1997, pp. 216-218
Authors:
XIAO ZS
GOLDSTEIN JA
XIE HG
BLAISDELL J
WANG W
JIANG CH
YAN FX
HE N
HUANG SL
XU ZH
ZHOU HH
Citation: Zs. Xiao et al., DIFFERENCES IN THE INCIDENCE OF THE CYP2C19 POLYMORPHISM AFFECTING THE S-MEPHENYTOIN PHENOTYPE IN CHINESE HAN AND BAI POPULATIONS AND IDENTIFICATION OF A NEW RARE CYP2C19 MUTANT ALLELE, The Journal of pharmacology and experimental therapeutics, 281(1), 1997, pp. 604-609
Citation: Hg. Xie, DIRECT EVIDENCE FOR THE HIGHER FREQUENCY OF CYP2C19 ALLELIC HETEROZYGOTES IN CHINESE SUBJECTS THAN IN WHITE SUBJECTS, Clinical pharmacology and therapeutics, 62(6), 1997, pp. 691-692
Authors:
XIE HG
XU ZH
LUO XA
HUANG SL
ZENG FD
ZHOU HH
Citation: Hg. Xie et al., GENETIC POLYMORPHISMS OF DEBRISOQUINE AND S-MEPHENYTOIN OXIDATION METABOLISM IN CHINESE POPULATIONS - A METAANALYSIS, Pharmacogenetics, 6(3), 1996, pp. 235-238
Citation: Zh. Xu et al., IN-VIVO INHIBITION OF CYP2C19 BUT NOT CYP2D6 BY FLUVOXAMINE, British journal of clinical pharmacology, 42(4), 1996, pp. 518-521
Citation: Hg. Xie et al., HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF URINARY 4'-HYDROXYMEPHENYTOIN, A METABOLIC MARKER FOR THE HEPATIC ENZYME CYP2C19, IN HUMANS, Journal of chromatography B. Biomedical applications, 668(1), 1995, pp. 125-131
Citation: Hg. Xie et X. Chen, SEX-DIFFERENCES IN PHARMACOKINETICS OF ORAL PROPRANOLOL IN HEALTHY CHINESE VOLUNTEERS, Zhongguo yaoli xuebao, 16(5), 1995, pp. 468-470
Citation: Hg. Xie et Hh. Zhou, ASSAY OF METOPROLOL AND ALPHA-HYDROXYMETO PROLOL IN HUMAN URINE BY REVERSED-PHASE LIQUID-CHROMATOGRAPHY WITH DIRECT-INJECTION, Zhongguo yaoli xuebao, 16(1), 1995, pp. 32-35
Authors:
DEMORAIS SMF
GOLDSTEIN JA
XIE HG
HUANG SL
LU YQ
XIA H
XIAO ZS
ILE N
ZHOU HH
Citation: Smf. Demorais et al., GENETIC-ANALYSIS OF THE S-MEPHENYTOIN POLYMORPHISM IN A CHINESE POPULATION, Clinical pharmacology and therapeutics, 58(4), 1995, pp. 404-411
Citation: R. He et al., ENGINE FLAME IMAGING USING ELECTRICAL CAPACITANCE TOMOGRAPHY (VOL 30,PG 559, 1994), Electronics Letters, 30(11), 1994, pp. 917-917